marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Esperion Therapeutics Cash Flow 2011-2024 | ESPR
Annual Cash Flow Esperion Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-135 M | -175 M | -264 M | -85.2 M | -70.3 M | -149 M | -131 M | -47.7 M | -38.2 M | - | - | - | - |
Depreciation & Amortization |
164 K | 500 K | 612 K | 547 K | 319 K | 265 K | 258 K | 252 K | 236 K | 160 K | 71 K | 139 K | 178 K |
Accounts Payables |
31.7 M | 23 M | 17.6 M | 52 M | 28.9 M | 44.9 M | 20.4 M | 4.6 M | 707 K | 2.04 M | 2.23 M | - | - |
Accounts Receivables |
48.5 M | 33.7 M | 22.9 M | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
65.6 M | 35.2 M | 34.4 M | 16.1 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Esperion Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 53.8 M | - | - | -54.4 M | - | -132 M | - | -39 M | - | -206 M | - | -89.1 M | - | -16.6 M | 70 M | -69.3 M | - | -20.3 M | 37.7 M | 91.7 M | - | -120 M | -82.4 M | -43.2 M | - | -96.4 M | -60.5 M | -34.3 M | - | -31.4 M | -17.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | 81 K | - | 408 K | - | 153 K | - | 459 K | - | 153 K | - | 387 K | 224 K | 106 K | - | 218 K | 126 K | 71 K | - | 191 K | 124 K | 61 K | - | 196 K | 134 K | 69 K | - | 190 K | 127 K | 64 K | - | 169 K | 115 K | 59 K | - | 104 K | 53 K | 12 K | - | 60 K | 49 K | 32 K | - | 107 K | 72 K | - | - | - | - | - |
Accounts Payables |
34.9 M | 47.7 M | 28.4 M | 26.2 M | 24.6 M | 17.1 M | 23 M | 18.6 M | - | 26.8 M | 17.6 M | 20.7 M | 29.4 M | 30.3 M | 52 M | 52 M | 52 M | 52 M | 28.9 M | 28.9 M | 28.9 M | 28.9 M | 44.9 M | 44.9 M | 44.9 M | 44.9 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 4.6 M | 4.6 M | 4.6 M | 4.6 M | 707 K | 707 K | 707 K | 707 K | 2.04 M | 2.04 M | 2.04 M | 2.04 M | 2.23 M | 2.23 M | 2.23 M | 2.23 M | 476 K | 476 K | 476 K | - | - | - | - | - |
Accounts Receivables |
67.8 M | 60.4 M | 54.6 M | 42.6 M | 40.8 M | 36.4 M | 33.7 M | 31.5 M | - | 25.1 M | 22.9 M | 21.7 M | 21.9 M | 17.3 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
80.1 M | 84.5 M | 73.1 M | 51.4 M | 45.7 M | 39.4 M | 35.2 M | 29.5 M | - | 35.7 M | 34.4 M | 34 M | 23.7 M | 20 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency